Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA'S FIRST MEDICAL…
In 2024, Malaysia welcomed 1.6 million healthcare travellers, reflecting a 14% year-on-year increase, and generated RM2.72 billion in revenue, a remarkable 21% growth compared to 2023. MYMT 2026 is poised to elevate these achievements, aligning with MHTC's ambitious goal of achieving RM12 billion in industry revenue by 2030. In 2024,Malaysiawelcomed 1.6 million healthcare travellers, reflecting a 14% year-on-year increase, and generatedRM2.72 billionin revenue, a remarkable 21%...
PR Newswire
25/07/2025
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of…
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit and prolonged PFS compared to VRd aloneWith the first global approval in TE NDMM, Sarclisa is now approved in the EU across all lines of therapy, regardless of transplant eligibilityParis, July 25, 2025.Following thepositive...
Nasdaq GlobeNewswire
25/07/2025
Memo Therapeutics AG Announces Phase II Trial Results for Potravitug in Kidney…
Results show biopsy-proven resolution of BK polyomavirus nephropathy in kidney transplant recipients No safety or tolerability concerns were observedSupports progression into Phase III development with the potential to transform the treatment landscape for kidney transplant patients with BK polyomavirus infectionFurther results from the trial to be presented at the World Transplant Congress in San Francisco, 2-6 August Schlieren / Zurich, Switzerland, 25 July, 2025 – Memo...
Nasdaq GlobeNewswire
25/07/2025
CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in…
Key Takeaways from the CD40/CD40L Inhibitors Market Report Key Takeaways from the CD40/CD40L Inhibitors Market Report Discover which indication is expected to grab the major CD40/CD40L inhibitors market share @CD40/CD40L Inhibitors Market Report CD40/CD40L Inhibitors Market Dynamics The CD40/CD40L signaling pathway plays a pivotal role in modulatingimmune responses, inflammation, and tumor immunity. Overactivation of this pathway has been implicated in a variety of...
PR Newswire
24/07/2025
B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During…
Key Takeaways from the B7-H4 Targeting Therapies Market Report Key Takeaways from the B7-H4 Targeting Therapies Market Report Discover which indication is expected to grab the major B7-H4 targeting therapies market share @B7-H4 Targeting Therapies Market Report B7-H4 Targeting Therapies Market Dynamics The B7-H4 targeting therapies market is rapidly emerging as a promising frontier in immuno-oncology. B7-H4 is a member of the B7 family of immune checkpoint molecules that has...
PR Newswire
24/07/2025
Cabometyx® approved in the EU for previously treated advanced neuroendocrine…
Cabometyx ®is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy 1 ,2 Approval based on pivotal CABINET Phase III trial which demonstrated a 77% and 62% reduction in the risk of disease progression or death versus placebo in advanced pancreatic and extra-pancreatic neuroendocrine tumors, respectively...
Nasdaq GlobeNewswire
24/07/2025
OXURION : Information on the Total Number of Voting Rights (Denominator)…
Atlas Special Opportunities, LLC has converted 7 convertible bonds in Oxurion resulting in a EUR 175,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1] that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential market…
Actusnews Wire
24/07/2025
Guerbet : H1 2025 revenue
H1 2025 revenueFirst-half activityH1 revenue of €387.8 million, down 5.4% at CER 1and like-for-like 2largely due to the fall in activity in FranceSales at CER and on a like-for-like basis increased in EMEA excluding France (+6.9%), were stable in the Americas (-0.3%) and fell in Asia (-7.3%)Double-digit growth is expected in H2, driven primarily by a more favorable comparison base and the normalization of activity in France Full-year targets confirmedRevenue growth...
Nasdaq GlobeNewswire
24/07/2025
Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR |…
Browse in-depth TOC on "Knee Replacement Surgery Market" Browse in-depth TOC on "Knee Replacement Surgery Market" 300 - Tables 55 - Figures 400 - Pages By product,the global knee replacement surgery market is segmented into knee implants, knee braces & support systems, and orthobiologics. The orthobiologics segment is expected to register significant growth over the forecast period. A growing number of patients are opting for non-surgical interventions to manage their...
PR Newswire
24/07/2025
Tronsmart's New Bang 2, T8, T8 Mini & Trip 2 Soundtrack Outdoor Thrill and…
Bang 2: Dominate Outdoor Party with Booming BassPowered by SoundPulse technology, the Bang 2 party speaker boosts 90W of deeper bass through a 2.1-channel system, featuring a racetrack mid-woofer for richer stereo, ensuring your playlist energizes the entire crowd. Its detachable strap and built-in handle make it easy to carry parties anywhere, while IPX6 waterproof keeps the fun going. The 26 hours of playtime fuels beach sunrises to bonfire finales. Plus, its party light also syncs to the…
PR Newswire
24/07/2025
Global Smart Toilet Market Poised for Rapid Growth, Projected to Reach USD 28.4…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=253141 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=253141 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Smart Toilet Market Overview 1. Rising Demand for Smart Sanitation Solutions The increasing emphasis on hygiene and convenience is driving the demand for smart toilets. These advanced sanitation systems offer features such...
PR Newswire
24/07/2025
Patient Registry Software Market worth $3.61 billion by 2030 with 9.8% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594 Browse in-depth TOC on "Patient Registry Software Market" 150 - Tables50 - Figures360 - Pages By registry type, the patient registry software market is categorized by registry type into two main segments: disease registries and product registries. The disease registries segment includes...
PR Newswire
24/07/2025
Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia
The 200,000 square-foot facility will immediately employ 30 people and will serve as the production hub for film coatings in the Asia Pacific region. Designed with cutting-edge technology and energy-efficient systems, the new plant reinforces Colorcon's dedication to industry innovation, superior quality, regulatory leadership and environmental stewardship. The 200,000 square-foot facility will immediately employ 30 people and will serve as the production hub for film coatings in theAsia...
PR Newswire
24/07/2025
Healthcare Consulting Services Market is expected to generate a revenue of USD…
The Healthcare Consulting Services Market is expanding rapidly as healthcare providers, payers, and life sciences companies seek strategic support to streamline operations, implement digital health technologies, and comply with regulatory reforms globally. The Healthcare Consulting Services Market is expanding rapidly as healthcare providers, payers, and life sciences companies seek strategic support to streamline operations, implement digital health technologies, and comply with regulatory...
PR Newswire
24/07/2025
Rumours of a Potential Takeover Offer for Bavarian Nordic A/S
COPENHAGEN, Denmark, July 24, 2025– Bavarian Nordic A/S (OMX: BAVA) has become aware of market rumours regarding a potential takeover offer for Bavarian Nordic A/S by a consortium consisting of Nordic Capital and Permira.Bavarian Nordic A/S can confirm that we have been in discussions with Nordic Capital and Permira regarding a potential takeover offer for Bavarian Nordic A/S by Nordic Capital and Permira.As these discussions are continuing, there can be no certainty as to whether any...
Nasdaq GlobeNewswire
24/07/2025
ACTO LAUNCHES CXZONE: THE FIRST AI-SIMULATED ROLEPLAY SOLUTION BUILT EXCLUSIVELY…
CxZone gives field reps and MSLs judgment-free, on-demand practice with instant feedback aligned to a company's unique sales process and coaching models. Unlike generic AI roleplay tools, CxZone goes beyond basic sales skill development, focusing on what matters most in HCP conversations—clinical fluency and product messaging. Practice scenarios in CxZone can be built around content auto-synced with Veeva PromoMats and MedComms, ensuring field professionals always practice with current, approved…
PR Newswire
24/07/2025
Endo Presents Plantar Fibromatosis and Plantar Fasciitis Data at the American…
"We're pleased to share clinical trial data with healthcare providers as part of our ongoing efforts to help improve patient care and highlight our clinical development strategy," said James P. Tursi, M.D., Executive Vice President, Global Research & Development at Endo. "We are advancing a Phase 3 study aimed at exploring a potential nonsurgical treatment option for patients with PFI, further demonstrating our commitment to developing medicines that address challenging and…
PR Newswire
24/07/2025
hūmānus and ARSPHR Launch Groundbreaking Rohingya Atrocities Archive, Continuing…
The archive directly continues the mission of Mohibullah , the courageous Rohingya advocate who was tragically assassinated in 2021. Known in the camps simply as "Peace Father," Mohibullah famously declared,"If I die, it's okay. I will give my life for my community."This dynamic, living archive embodies his unwavering commitment, detailing the profound violence, harm, and losses experienced by Rohingya families during the military operations of 2016 and 2017. It currently…
PR Newswire
24/07/2025
Seegene unveils the world's first unattended PCR automation, igniting a global…
CURECA™ is the world's first system to fully automate the entire PCR testing process – from sample storage and pre-treatment to nucleic acid extraction, amplification, and result analysis – without any human intervention. Designed for 24/7 continuous operation, the system minimizes human error and dramatically improves the consistency and reliability of the test results. CURECA™ is the world's first system to fully automate the entire PCR testing process – from sample storage and…
PR Newswire
24/07/2025
iOnctura Strengthens Medical and Commercialization Expertise with Two…
Catherine Pickering, CEO and co-founder of iOnctura, commented, "We are thrilled to welcome Neil and Anthony to our Board at this pivotal time in iOnctura's growth. Their expertise and experience in oncology drug development and global commercialization will be instrumental as we progress our innovative pipeline through development and towards the market." Catherine Pickering, CEO and co-founder of iOnctura, commented, "We are thrilled to welcome Neil and Anthony to our Board at…
PR Newswire
24/07/2025
Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of…
The objective of the collaboration is to identify and characterize monoclonal antibodies with potent neutralizing activity against a clinically relevant human viral pathogen. Insights gained from this joint discovery effort may enable the development of next-generaton antiviral therapeutics and inform the design of more efficacious vaccine candidates. The objective of the collaboration is to identify and characterize monoclonal antibodies with potent neutralizing activity against a clinically...
PR Newswire
24/07/2025
AB Science has received approval from several European countries to initiate the…
PRESS RELEASEAB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSISTHIS APPROVAL FOLLOWS PROTOCOL VALIDATION BY THE EMA AND FDA AUTHORIZATIONParis, July 24, 2025, 8am CETAB Science SA(Euronext - FR0010557264 - AB) today announced that the confirmatory Phase 3 study with masitinib in amyotrophic lateral sclerosis (ALS), study AB23005, has been authorized by the first set of...
Nasdaq GlobeNewswire
24/07/2025
Invitation to attend Systemair AB's (publ) Annual General Meeting 2025
In accordance with the provisions of Chapter 7, Section 4a of the Swedish Companies Act and the Company's Articles of Association, the Board of Directors (the "Board") has decided that, as an alternative for shareholders who do not attend the meeting in person, postal voting will be possible. Shareholders can therefore choose to exercise their voting rights at the AGM by attending in person, by proxy or by postal vote. In accordance with the provisions of Chapter 7, Section 4a of the…
PR Newswire
24/07/2025
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum…
Basel, 24 July 2025Group salesgrew by 7% 1at constant exchange rates (CER; 4% in CHF), driven by strong demand for medicines. Pharmaceuticals Division salesrose by 10% (6% in CHF), with Phesgo (breast cancer), Xolair (food allergies), Hemlibra (haemophilia A), Vabysmo (severe eye diseases) and Ocrevus (multiple sclerosis) being the top growth drivers. Diagnostics Division saleswere stable (-3% in CHF) as strong demand for pathology solutions and blood screening tests offset...
Nasdaq GlobeNewswire
24/07/2025
Altri Comunicati
